← Back to Search

Combination Interventions for Anemia

N/A
Waitlist Available
Led By Eric Thomas, MD,MPH
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* new, significant abnormal anemia (Hgb \>1g/dl below normal, with normal white cells and platelets) or decreased estimated glomerular filtration rate (eGFR) (\<60 ml/min/1.73m2 ) seen in one of the University of Texas Physicians (UTP) adult primary care clinics.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 1 to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial assesses how EBIs affect patient safety & efficiency, & identifies any barriers that could affect their implementation.

Who is the study for?
This trial is for adults with new, significant anemia or reduced kidney function (eGFR <60 ml/min/1.73m2) seen at University of Texas Physicians clinics. It's not suitable for those who don't meet these specific blood and kidney health criteria.
What is being tested?
The study tests whether usual care combined with specialist consultations improves patient safety and efficiency in diagnosing primary care conditions like anemia and reduced kidney function.
What are the potential side effects?
Since the interventions involve usual medical care and additional specialist advice, side effects are not a primary concern of this trial but will depend on individual treatments received as part of standard care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 1 to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and between 1 to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Cost of treatment
Patient activation as assessed by the short form of the Patient Activation Measure (PAM)
Percentage of tests appropriately utilized
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Step 4 (4 clinics) - 24 months control followed by 6 months of interventionExperimental Treatment2 Interventions
Group II: Step 3 (3 clinics) - 18 months control followed by 12 months of interventionExperimental Treatment2 Interventions
Group III: Step 2 (3 clinics) - 12 months control followed by 18 months of interventionExperimental Treatment2 Interventions
Group IV: Step 1 (3 clinics) - 6 months control followed by 24 months of interventionExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
946 Previous Clinical Trials
343,081 Total Patients Enrolled
3 Trials studying Anemia
1,038 Patients Enrolled for Anemia
Eric Thomas, MD,MPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Evidence-Based Interventions Clinical Trial Eligibility Overview. Trial Name: NCT05735314 — N/A
Anemia Research Study Groups: Step 1 (3 clinics) - 6 months control followed by 24 months of intervention, Step 2 (3 clinics) - 12 months control followed by 18 months of intervention, Step 3 (3 clinics) - 18 months control followed by 12 months of intervention, Step 4 (4 clinics) - 24 months control followed by 6 months of intervention
Anemia Clinical Trial 2023: Evidence-Based Interventions Highlights & Side Effects. Trial Name: NCT05735314 — N/A
Evidence-Based Interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05735314 — N/A
~249 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top